This morning, Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN) and WILD Flavors Inc., announced they will participate at upcoming food and beverage industry supplier conferences during the month of November.

WILD Flavors will also represent Sunwin Stevia extract products at the Private Label Manufacturers Association's 2009 Private Label Trade Show in Chicago November 15-17, the only trade show devoted entirely to store brands. The show at the Rosemont Convention Center will feature more than 2,000 convention booths and companies from more than 35 countries worldwide.

Commenting on these events, Jeff Reynolds, President of Sunwin USA said, "We have a number of events planned in the month of November to increase the exposure of Sunwin's Stevia extracts aimed at the US market as well as our expansive Stevia formulation capabilities through WILD Flavors -- one of the world's top natural food and beverage development companies. Sunwin Stevia extracts can be combined with specialized WILD Flavors flavor enhancements to achieve specific taste profiles, broadening the range of Stevia uses to almost any food and beverage category. We are now seeing the benefits of our strategic alignment forged earlier in 2009 as Sunwin Stevia extracts are ready for use in a wide variety of name brand and private label products to give consumers a natural no calorie sweetener option suited for today's health conscious consumer."

The stock closed yesterday at around Twenty Five cents a share.

For an in-depth profile of Sunwin International Neutraceuticals, visit http://wallstreetenews.com/view-company-profiles.php?profile=SUWN_072909.

To receive FREE Mobile Stock Alerts formatted especially for your cell phone, text the word "press" in the subject line to 68494.

For more information, please visit www.WallStreetNewsAlert.com and you can also follow Wall Street News Alerts on Twitter at http://twitter.com/wsna

Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) up 2.2% on 5.5 million shares traded. Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 20 pharmaceutical companies in the world and is the world's leading generic pharmaceutical company.

Merck & Co., Inc. (NYSE: MRK) up 2.5% on 29.1 million shares traded.

Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first.

Bank of America Corp.